[ET Net News Agency, 26 March 2021] Shanghai FudanZhangjiang Bio-Pharmaceutical Co.,
Ltd. (01349) said its profit attributable to shareholders of the company was RMB164.66
million for the year ended 31 December 2020, a year-on-year decrease of 27.58%. The basic
earnings per share were RMB0.1663. A final dividend of RMB0.05 will be distributed.
The revenue was RMB833.8 million, a year-on-year decrease of 18.99%. (RC)